|
Emax (% ± S.E.M.) |
|
Emax (% ± S.E.M.) |
Term-pregnant uterus |
|
|
Preterm-pregnant uterus |
|
|
N/OFQ |
29.07 ± 1.61 |
|
N/OFQ |
27.51 ± 4.31 |
|
N/OFQ + NST |
43.79 ± 3.61 |
*** |
N/OFQ + NST |
56.29 ± 4.94 |
*** |
NST |
42.01 ± 9.48 |
|
NST |
35.55 ± 6.58 |
|
NST + N/OFQ |
38.24 ± 7.05 |
ns |
NST + N/OFQ |
37.92 ± 7.40 |
ns |
|
p<0.001; significances are expressed relative to N/OFQ. ns: non-significant; significances are expressed relative to NST |
Table 1: Maximum uterus-relaxant values of nociceptin (N/OFQ) alone and in the presence of Nocistatin (NST); and of NST alone and in the presence of N/OFQ on
oxytocin-stimulated uterine contractions on the term- and preterm-pregnant human myometrium in vitro. |